Table 1

Baseline characteristics of the cohort and the management of the SVT

Baseline characteristicPARA group (n=44)ED group (n=42)p Value
Age (years)48±1653±180.16
Male14 (32)22 (52)0.08
Previous history of symptoms34 (77)36 (86)0.41
Previously sought medical advice33 (75)33 (79)0.80
 General practitioner23 (52)14 (33)0.09
 Accident and emergency23 (52)23 (55)0.83
 Cardiologist22 (50)23 (55)0.67
 Paramedic21 (48)22 (52)0.86
 More than once10 (23)11 (26)0.80
Previous catheter ablation3 (7)1 (2)0.62
Awaiting or offered catheter ablation5 (11)5 (12)1.00
On antiarrhythmic drugs6 14)5 (12)1.00
On rate-controlling drugs11 (25)10 (24)1.00
 Bisoprolol6 (55)5 (50)1.00
 Atenolol1 (9)3 (30)0.31
 Verapamil4 (36)2 (20)0.64
Hypertension2 (5)5 (12)0.26
Type 2 diabetes mellitus3 (7)4 (10)0.71
Thyroid dysfunction1 (2)01.00
Vagal manoeuvres performed28 (64)27 (64)1.00
 Successful1 (4)2 (7)0.61
Adenosine administered37 (84)25 (60)0.02*
Adenosine not administered7 (16)17 (40)0.02*
 No intravenous access available1 (14)00.35
 Adenosine not available1 (14)00.35
 Vagal manoeuvres successfully terminated tachycardia1 (14)2 (15)1.00
 Vagal manoeuvres demonstrated underlying atrial flutter1 (14)00.35
 Tachycardia spontaneously terminated before treatment3 (43)12 (71)0.01*
 Given antiarrhythmic drugs001.00
 Given rate-controlling drug02 (15)1.00
 Unclear01 (3)1.00
Adenosine 6 mg successful26 (70)20 (80)0.56
Adenosine 6 mg successful but tachycardia re-initiated2 (8)1 (4)1.00
 Patient transferred to ED1 (50)N/AN/A
 Adenosine 12 mg given (protocol violation)1 (50)N/AN/A
Adenosine 12 mg successful3 (8)3 (12)1.00
Adenosine 12 mg successful but tachycardia re-initiated3 (8)00.27
Dose given not available02 (8)0.16
  • Values are n (%) or mean±SD.

  • ED, emergency department; PARA, treated by paramedic; SVT, supraventricular tachycardia.